Physician profile
David W Key
NPI 1518075936
$14,553.88
in general payments reported to CMS, 2019-2025
54 companies · $7,151 in 2025
The $7,151 reported for 2025 was more than what 92% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,031 · 2020: $218 · 2021: $597 · 2022: $1,253 · 2023: $1,989 · 2024: $2,314 · 2025: $7,151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,298 · Food and Beverage: $4,141 · Travel and Lodging: $1,915 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,298.00 |
| Food and Beverage | $4,141.32 |
| Travel and Lodging | $1,915.10 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $4,842.52 | 2019-2025 | |
| Curium US LLC | $1,284.35 | 2025 | Detectnet |
| Ferring Pharmaceuticals INC. | $1,048.34 | 2024-2025 | Adstiladrin |
| Procept Biorobotics Corporation | $824.89 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Astellas Pharma US INC | $550.39 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Janssen Biotech, INC. | $469.17 | 2019-2025 | Erleada, Akeega |
| Pfizer INC. | $455.44 | 2019-2025 | |
| Blue Earth Diagnostics | $432.46 | 2019-2025 | Posluma |
| Dornier Medtech America, INC | $384.06 | 2022-2023 | Dornier Medtech |
| Sumitomo Pharma America, INC. | $368.88 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Scientific Affairs, LLC | $352.96 | 2019-2025 | Pipeline, Akeega, Erleada |
| Dendreon Pharmaceuticals LLC | $314.56 | 2019-2025 | Provenge |
| Boston Scientific Corporation | $295.58 | 2022-2024 | Lithoclast, Lithovue |
| Teleflex LLC | $276.77 | 2021-2024 | Urolift |
| Urogen Pharma, INC. | $238.13 | 2021-2024 | Jelmyto |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $193.75 | 2021-2024 | Keytruda, Lynparza, Welireg |
| Abbvie INC. | $192.25 | 2019-2025 | |
| Rochester Medical Corporation | $168.36 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $159.85 | 2022-2025 | |
| Tolmar Pharmaceuticals, INC. | $124.91 | 2019-2021 | |
| Myovant Sciences INC. | $114.57 | 2021-2022 | |
| Coloplast Corp | $114.35 | 2019-2021 | |
| Tolmar, INC. | $103.70 | 2023-2025 | Eligard, Jatenzo |
| Myriad Genetic Laboratories, INC. | $101.27 | 2021-2025 | Prolaris |
| Astrazeneca Pharmaceuticals LP | $100.51 | 2022-2024 | Lynparza |
| Accord Healthcare, INC. | $82.65 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $67.78 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $67.73 | 2023-2025 | Pylarify |
| Axonics, INC. | $67.19 | 2020-2024 | Axonics |
| Alexion Pharmaceuticals, INC. | $62.38 | 2024-2025 | Ultomiris |
| Immunitybio, INC. | $61.02 | 2024-2025 | |
| Urovant Sciences INC | $60.31 | 2022 | |
| Laborie Medical Technologies Corp. | $55.36 | 2025 | Endosheath Technology |
| Verity Pharmaceuticals INC. | $51.51 | 2023-2025 | Trelstar, Tlando |
| Caris Mpi, INC. | $48.27 | 2025 | Mi Cancer Seek |
| Amgen INC. | $44.46 | 2021-2024 | Prolia |
| Neotract INC. | $39.92 | 2019 | |
| Photocure INC | $39.34 | 2022-2025 | Cysview |
| Tempus Ai, INC | $39.25 | 2024-2025 | Xt Cdx |
| Edap Technomed INC | $33.60 | 2023 | |
| Foundation Medicine, INC. | $32.28 | 2020-2022 | |
| C. R. Bard, INC. & Subsidiaries | $25.81 | 2019-2025 | Bard Urinary Drainage Bag |
| Hollister Incorporated | $25.66 | 2023 | Vapro Plus Pocket, Infyna Chic |
| Kerecis Limited | $21.38 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Genzyme Corporation | $20.12 | 2021 | |
| Antares Pharma, INC. | $20.07 | 2022 | |
| Olympus America INC. | $15.26 | 2023 | Oes Cystonephrofiberscope |
| Sagent Pharmaceuticals | $13.22 | 2023 | Glydo |
| Endo Pharmaceuticals INC. | $12.86 | 2021 | |
| Gilead Sciences, INC. | $11.95 | 2022 | |
| Allergan, INC. | $11.29 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $11.19 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$653.37 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Key listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.